Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Axcan-Schwarz joint venture to market URSO

Dec. 2, 1996

Chugai discloses erythromycins for gastrointestinal disorders

Nov. 27, 1996

OraVax and Pasteur-Merieux Connaught license H. pylori genome sequence

Nov. 26, 1996

Lilly claims 5-HT7 antagonist for GI indications

Nov. 26, 1996

New market introduction for proton pump inhibitor

Nov. 26, 1996

Neose reports promising phase I results for novel antiulcer drug

Nov. 25, 1996

PDL anti-HBV antibody enters phase II

Nov. 22, 1996

Novavax reports progress on products for H. pylori infection

Nov. 22, 1996

Anti-H. pylori compounds from Fujisawa

Nov. 21, 1996

Chugai describes agents that stimulate gastrointestinal motility

Nov. 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...